Market Research Report
Europe Lactoferrin Market By Function, By Application, By Country, Growth Potential, COVID-19 Impact Analysis Report and Forecast, 2021 - 2027
|Europe Lactoferrin Market By Function, By Application, By Country, Growth Potential, COVID-19 Impact Analysis Report and Forecast, 2021 - 2027|
Published: August 31, 2021
Content info: 83 Pages
Delivery time: 1-2 business days
The Europe Lactoferrin Market would witness market growth of 8.34% CAGR during the forecast period (2021-2027).
Lactoferrin acts as the main solution for anemia, its high degree of bioavailability combined with the ability to boost serum ferritin levels by five times enables effective absorption of iron in comparison to other iron sources. As per the WHO, there are above 1.62 people affected by individuals around the world, with the maximum rate witnessed among pre-school-going children. Lactoferrin is a modern solution for anemia and is broadly known to be a part of the transferrin family, which has the capability of controlling the levels of free iron in body fluid combined with boosting the hemoglobin percentage by improving the ability to bind iron.
The surge in the occurrence of viral and bacterial infections around the world is one of the major trends of the European lactoferrin market in the last couple of years. Moreover, the governments of various countries of this region are undertaking different types of initiatives to promote breastfeeding, thereby hampering the growth of the regional lactoferrin market. Moreover, the regional market is also fuelled by the rising consumer awareness regarding the benefits of lactoferrin-based products, hence propelling the demand of the regional market.
Lactoferrin is widely used in decreasing dermal immune response and healing wounds by stimulating connective tissue with epidermal cells by recreating the skin. Its calming effect on inflammations eliminates the possibility of the formation of larger zits and cysts. The majority of the clinical trials have displayed that lactoferrin can also be efficiently utilized in the treatment and prevention of gastrointestinal inflammatory cases. Growing consumer awareness about gut health along with the surging product demand to eliminate the chances of bloating and irritable bowel movement and to decrease intestinal inflammation would augment the development of the lactoferrin market during the forecast period.
The Germany market dominated the Europe Personal Care Products Market by Country in 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $2,580.8 Thousands by 2027. The UK market is exhibiting a CAGR of 7.7% during (2021 - 2027). Additionally, The Spain market is anticipated to witness a CAGR of 9.5% during (2021 - 2027).
Based on Function, the market is segmented into Iron absorption, Intestinal flora protection, Immune cell stimulation, Antioxidant, Antibacterial and Anti-inflammatory. Based on Application, the market is segmented into Pharmaceuticals, Food & Beverages, Personal Care Products, Infant Formula, Sports & Functional Foods and Animal Feed. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Royal FrieslandCampina N.V., Glanbia PLC, Fonterra Co-operative Group Limited, Moringa Milk Industry Co., Ltd., Ventria Bioscience, Inc. (InVitria), Farbest Brands, Bega Cheese Ltd (Tatura Milk Industries Ltd.), MP Biomedicals LLC (Valiant Co., Ltd.), Synlait Milk Limited, and Pharming Group NV.
Market Segments covered in the Report:
Unique Offerings from KBV Research
List of Figures